Skip to main content
. 2008 Oct 15;80(2):286–294. doi: 10.1095/biolreprod.108.070102

FIG. 5.

FIG. 5.

A summary of the ligand-mediated control of TRP53 expression via the PI3 kinase/AKT/MDM2 pathway. The points of action of the pharmacological inhibitors and genetically modified lines used in this study are shown in italics in shaded boxes. The symbol “?” indicates interactions that have not yet been demonstrated to occur in the early embryo.